mifobate has been researched along with troglitazone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, T; Chihara, J; Hamada, K; Kamada, Y; Kanda, A; Kayaba, H; Matsuwaki, Y; Oyamada, H; Ueki, S; Yamaguchi, K | 1 |
| Farghali, H; Hodis, J; VaclavĂková, R | 1 |
2 other study(ies) available for mifobate and troglitazone
| Article | Year |
|---|---|
The synthetic PPARgamma agonist troglitazone inhibits IL-5-induced CD69 upregulation and eosinophil-derived neurotoxin release from eosinophils.
Topics: Analysis of Variance; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Cells, Cultured; Chromans; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Eosinophil-Derived Neurotoxin; Eosinophils; Flow Cytometry; Humans; Interleukin-5; Lectins, C-Type; Organophosphorus Compounds; PPAR gamma; Thiazolidinediones; Troglitazone; Up-Regulation | 2005 |
Beta-3 agonist-induced lipolysis and nitric oxide production: relationship to PPARgamma agonist/antagonist and AMP kinase modulation.
Topics: Adenylate Kinase; Adipocytes; Adrenergic beta-3 Receptor Agonists; Animals; Chromans; Ethanolamines; Glycerol; Lipolysis; Male; Nitric Oxide; Nitric Oxide Synthase; Organophosphorus Compounds; PPAR gamma; Rats; Rats, Wistar; Receptor Cross-Talk; Thiazolidinediones; Troglitazone | 2011 |